nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—ALB—liver cancer	0.644	1	CbGaD
Salicylic acid—L-Phenylalanine—TAT—liver cancer	0.0064	0.443	CrCbGaD
Salicylic acid—Acetylsalicylic acid—TP53—liver cancer	0.00359	0.248	CrCbGaD
Salicylic acid—Skin exfoliation—Sorafenib—liver cancer	0.0022	0.045	CcSEcCtD
Salicylic acid—Mesalazine—PPARG—liver cancer	0.00193	0.134	CrCbGaD
Salicylic acid—Abdominal pain upper—Sorafenib—liver cancer	0.00153	0.0313	CcSEcCtD
Salicylic acid—Gastric ulcer—Epirubicin—liver cancer	0.00147	0.03	CcSEcCtD
Salicylic acid—Abdominal discomfort—Sorafenib—liver cancer	0.00139	0.0284	CcSEcCtD
Salicylic acid—Gastric ulcer—Doxorubicin—liver cancer	0.00136	0.0277	CcSEcCtD
Salicylic acid—Burning sensation—Epirubicin—liver cancer	0.00123	0.0251	CcSEcCtD
Salicylic acid—Epistaxis—Sorafenib—liver cancer	0.00122	0.0249	CcSEcCtD
Salicylic acid—Burning sensation—Doxorubicin—liver cancer	0.00113	0.0232	CcSEcCtD
Salicylic acid—Erythema multiforme—Sorafenib—liver cancer	0.00109	0.0224	CcSEcCtD
Salicylic acid—Tinnitus—Sorafenib—liver cancer	0.00108	0.0221	CcSEcCtD
Salicylic acid—Stinging—Epirubicin—liver cancer	0.00105	0.0215	CcSEcCtD
Salicylic acid—Erythema—Sorafenib—liver cancer	0.00101	0.0206	CcSEcCtD
Salicylic acid—Dysgeusia—Sorafenib—liver cancer	0.000986	0.0202	CcSEcCtD
Salicylic acid—Magnesium salicylate—ALB—liver cancer	0.000985	0.0681	CrCbGaD
Salicylic acid—Stinging—Doxorubicin—liver cancer	0.000972	0.0199	CcSEcCtD
Salicylic acid—Diflunisal—ALB—liver cancer	0.000926	0.0641	CrCbGaD
Salicylic acid—Skin exfoliation—Epirubicin—liver cancer	0.000813	0.0166	CcSEcCtD
Salicylic acid—Anorexia—Sorafenib—liver cancer	0.000783	0.016	CcSEcCtD
Salicylic acid—Oesophagitis—Epirubicin—liver cancer	0.000778	0.0159	CcSEcCtD
Salicylic acid—Ecchymosis—Epirubicin—liver cancer	0.00077	0.0158	CcSEcCtD
Salicylic acid—Skin exfoliation—Doxorubicin—liver cancer	0.000752	0.0154	CcSEcCtD
Salicylic acid—Dyspepsia—Sorafenib—liver cancer	0.000724	0.0148	CcSEcCtD
Salicylic acid—Oesophagitis—Doxorubicin—liver cancer	0.00072	0.0147	CcSEcCtD
Salicylic acid—Decreased appetite—Sorafenib—liver cancer	0.000715	0.0146	CcSEcCtD
Salicylic acid—Ecchymosis—Doxorubicin—liver cancer	0.000712	0.0146	CcSEcCtD
Salicylic acid—Pain—Sorafenib—liver cancer	0.000703	0.0144	CcSEcCtD
Salicylic acid—Constipation—Sorafenib—liver cancer	0.000703	0.0144	CcSEcCtD
Salicylic acid—Urticaria—Sorafenib—liver cancer	0.000653	0.0134	CcSEcCtD
Salicylic acid—Lethargy—Epirubicin—liver cancer	0.000631	0.0129	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—ALB—liver cancer	0.000626	0.0433	CrCbGaD
Salicylic acid—Lethargy—Doxorubicin—liver cancer	0.000584	0.0119	CcSEcCtD
Salicylic acid—Pruritus—Sorafenib—liver cancer	0.000582	0.0119	CcSEcCtD
Salicylic acid—Abdominal pain upper—Epirubicin—liver cancer	0.000564	0.0116	CcSEcCtD
Salicylic acid—Diarrhoea—Sorafenib—liver cancer	0.000562	0.0115	CcSEcCtD
Salicylic acid—Dizziness—Sorafenib—liver cancer	0.000544	0.0111	CcSEcCtD
Salicylic acid—Asthma—Epirubicin—liver cancer	0.000534	0.0109	CcSEcCtD
Salicylic acid—Vomiting—Sorafenib—liver cancer	0.000523	0.0107	CcSEcCtD
Salicylic acid—Abdominal pain upper—Doxorubicin—liver cancer	0.000522	0.0107	CcSEcCtD
Salicylic acid—Rash—Sorafenib—liver cancer	0.000518	0.0106	CcSEcCtD
Salicylic acid—Dermatitis—Sorafenib—liver cancer	0.000518	0.0106	CcSEcCtD
Salicylic acid—Headache—Sorafenib—liver cancer	0.000515	0.0105	CcSEcCtD
Salicylic acid—Asthma—Doxorubicin—liver cancer	0.000494	0.0101	CcSEcCtD
Salicylic acid—Nausea—Sorafenib—liver cancer	0.000488	0.00999	CcSEcCtD
Salicylic acid—Weight increased—Epirubicin—liver cancer	0.000486	0.00995	CcSEcCtD
Salicylic acid—Drowsiness—Epirubicin—liver cancer	0.000476	0.00975	CcSEcCtD
Salicylic acid—Weight increased—Doxorubicin—liver cancer	0.00045	0.00921	CcSEcCtD
Salicylic acid—Epistaxis—Epirubicin—liver cancer	0.000449	0.0092	CcSEcCtD
Salicylic acid—Drowsiness—Doxorubicin—liver cancer	0.000441	0.00902	CcSEcCtD
Salicylic acid—Hepatitis—Epirubicin—liver cancer	0.000428	0.00875	CcSEcCtD
Salicylic acid—Epistaxis—Doxorubicin—liver cancer	0.000416	0.00851	CcSEcCtD
Salicylic acid—Erythema multiforme—Epirubicin—liver cancer	0.000404	0.00828	CcSEcCtD
Salicylic acid—Tinnitus—Epirubicin—liver cancer	0.000399	0.00816	CcSEcCtD
Salicylic acid—Hepatitis—Doxorubicin—liver cancer	0.000396	0.0081	CcSEcCtD
Salicylic acid—Erythema multiforme—Doxorubicin—liver cancer	0.000374	0.00766	CcSEcCtD
Salicylic acid—Erythema—Epirubicin—liver cancer	0.000372	0.00762	CcSEcCtD
Salicylic acid—Tinnitus—Doxorubicin—liver cancer	0.000369	0.00755	CcSEcCtD
Salicylic acid—Dysgeusia—Epirubicin—liver cancer	0.000364	0.00746	CcSEcCtD
Salicylic acid—Erythema—Doxorubicin—liver cancer	0.000344	0.00705	CcSEcCtD
Salicylic acid—Dysgeusia—Doxorubicin—liver cancer	0.000337	0.0069	CcSEcCtD
Salicylic acid—Confusional state—Epirubicin—liver cancer	0.000306	0.00627	CcSEcCtD
Salicylic acid—Oedema—Epirubicin—liver cancer	0.000304	0.00622	CcSEcCtD
Salicylic acid—Anorexia—Epirubicin—liver cancer	0.00029	0.00593	CcSEcCtD
Salicylic acid—Confusional state—Doxorubicin—liver cancer	0.000283	0.0058	CcSEcCtD
Salicylic acid—Oedema—Doxorubicin—liver cancer	0.000281	0.00575	CcSEcCtD
Salicylic acid—Somnolence—Epirubicin—liver cancer	0.00027	0.00553	CcSEcCtD
Salicylic acid—Anorexia—Doxorubicin—liver cancer	0.000268	0.00548	CcSEcCtD
Salicylic acid—Dyspepsia—Epirubicin—liver cancer	0.000267	0.00547	CcSEcCtD
Salicylic acid—Decreased appetite—Epirubicin—liver cancer	0.000264	0.00541	CcSEcCtD
Salicylic acid—Pain—Epirubicin—liver cancer	0.00026	0.00532	CcSEcCtD
Salicylic acid—Constipation—Epirubicin—liver cancer	0.00026	0.00532	CcSEcCtD
Salicylic acid—Feeling abnormal—Epirubicin—liver cancer	0.00025	0.00512	CcSEcCtD
Salicylic acid—Somnolence—Doxorubicin—liver cancer	0.00025	0.00512	CcSEcCtD
Salicylic acid—Dyspepsia—Doxorubicin—liver cancer	0.000247	0.00506	CcSEcCtD
Salicylic acid—Decreased appetite—Doxorubicin—liver cancer	0.000244	0.005	CcSEcCtD
Salicylic acid—Urticaria—Epirubicin—liver cancer	0.000241	0.00494	CcSEcCtD
Salicylic acid—Pain—Doxorubicin—liver cancer	0.00024	0.00492	CcSEcCtD
Salicylic acid—Constipation—Doxorubicin—liver cancer	0.00024	0.00492	CcSEcCtD
Salicylic acid—Feeling abnormal—Doxorubicin—liver cancer	0.000232	0.00474	CcSEcCtD
Salicylic acid—Urticaria—Doxorubicin—liver cancer	0.000223	0.00457	CcSEcCtD
Salicylic acid—Pruritus—Epirubicin—liver cancer	0.000215	0.0044	CcSEcCtD
Salicylic acid—Diarrhoea—Epirubicin—liver cancer	0.000208	0.00425	CcSEcCtD
Salicylic acid—Dizziness—Epirubicin—liver cancer	0.000201	0.00411	CcSEcCtD
Salicylic acid—Pruritus—Doxorubicin—liver cancer	0.000199	0.00407	CcSEcCtD
Salicylic acid—Vomiting—Epirubicin—liver cancer	0.000193	0.00395	CcSEcCtD
Salicylic acid—Diarrhoea—Doxorubicin—liver cancer	0.000192	0.00394	CcSEcCtD
Salicylic acid—Rash—Epirubicin—liver cancer	0.000192	0.00392	CcSEcCtD
Salicylic acid—Dermatitis—Epirubicin—liver cancer	0.000191	0.00392	CcSEcCtD
Salicylic acid—Headache—Epirubicin—liver cancer	0.00019	0.0039	CcSEcCtD
Salicylic acid—Dizziness—Doxorubicin—liver cancer	0.000186	0.0038	CcSEcCtD
Salicylic acid—Nausea—Epirubicin—liver cancer	0.00018	0.00369	CcSEcCtD
Salicylic acid—Vomiting—Doxorubicin—liver cancer	0.000179	0.00366	CcSEcCtD
Salicylic acid—Rash—Doxorubicin—liver cancer	0.000177	0.00363	CcSEcCtD
Salicylic acid—Dermatitis—Doxorubicin—liver cancer	0.000177	0.00362	CcSEcCtD
Salicylic acid—Headache—Doxorubicin—liver cancer	0.000176	0.0036	CcSEcCtD
Salicylic acid—Nausea—Doxorubicin—liver cancer	0.000167	0.00342	CcSEcCtD
Salicylic acid—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	5.38e-05	0.000184	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CRABP1—liver cancer	5.37e-05	0.000184	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.36e-05	0.000183	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	5.32e-05	0.000182	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ADAM17—liver cancer	5.32e-05	0.000182	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCND1—liver cancer	5.32e-05	0.000182	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—JUN—liver cancer	5.31e-05	0.000181	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.29e-05	0.000181	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PSMA4—liver cancer	5.27e-05	0.00018	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PSMD10—liver cancer	5.27e-05	0.00018	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CTNNB1—liver cancer	5.27e-05	0.00018	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	5.24e-05	0.000179	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	5.23e-05	0.000179	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—PIK3CA—liver cancer	5.17e-05	0.000177	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GLUL—liver cancer	5.17e-05	0.000177	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CG—liver cancer	5.17e-05	0.000177	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CPT1B—liver cancer	5.17e-05	0.000177	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MMP9—liver cancer	5.16e-05	0.000176	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CDKN1A—liver cancer	5.14e-05	0.000176	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GOT2—liver cancer	5.13e-05	0.000175	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTA4—liver cancer	5.11e-05	0.000175	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MAPK8—liver cancer	5.02e-05	0.000171	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PSMA4—liver cancer	5e-05	0.000171	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PSMD10—liver cancer	5e-05	0.000171	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5e-05	0.000171	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	4.99e-05	0.00017	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PPARG—liver cancer	4.99e-05	0.00017	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTA2—liver cancer	4.98e-05	0.00017	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—NR1H4—liver cancer	4.98e-05	0.00017	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	4.91e-05	0.000168	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTA3—liver cancer	4.9e-05	0.000167	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—AKT1—liver cancer	4.86e-05	0.000166	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—GOT2—liver cancer	4.86e-05	0.000166	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.84e-05	0.000165	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CPT1B—liver cancer	4.83e-05	0.000165	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GLUL—liver cancer	4.83e-05	0.000165	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP2E1—liver cancer	4.82e-05	0.000165	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTA1—liver cancer	4.81e-05	0.000164	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—HRAS—liver cancer	4.78e-05	0.000163	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—NAT2—liver cancer	4.75e-05	0.000162	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	4.71e-05	0.000161	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—HPGDS—liver cancer	4.7e-05	0.00016	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.67e-05	0.00016	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.67e-05	0.00016	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—NR1H4—liver cancer	4.66e-05	0.000159	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MAPK14—liver cancer	4.64e-05	0.000158	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—VEGFA—liver cancer	4.64e-05	0.000158	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—STAT3—liver cancer	4.59e-05	0.000157	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	4.58e-05	0.000156	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IL6—liver cancer	4.58e-05	0.000156	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTA3—liver cancer	4.58e-05	0.000156	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.57e-05	0.000156	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ALDOB—liver cancer	4.56e-05	0.000156	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CD—liver cancer	4.54e-05	0.000155	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	4.52e-05	0.000154	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYCS—liver cancer	4.51e-05	0.000154	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	4.51e-05	0.000154	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—F2—liver cancer	4.49e-05	0.000154	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—ALB—liver cancer	4.49e-05	0.000153	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTA4—liver cancer	4.48e-05	0.000153	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GGT1—liver cancer	4.43e-05	0.000151	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GOT1—liver cancer	4.43e-05	0.000151	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	4.42e-05	0.000151	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTA2—liver cancer	4.37e-05	0.000149	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CRABP1—liver cancer	4.35e-05	0.000149	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	4.35e-05	0.000148	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PIK3CA—liver cancer	4.33e-05	0.000148	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CG—liver cancer	4.3e-05	0.000147	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MYC—liver cancer	4.26e-05	0.000146	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TGFB1—liver cancer	4.25e-05	0.000145	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.25e-05	0.000145	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—AKT1—liver cancer	4.22e-05	0.000144	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTA1—liver cancer	4.21e-05	0.000144	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	4.21e-05	0.000144	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.2e-05	0.000143	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—GOT1—liver cancer	4.2e-05	0.000143	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PSMD10—liver cancer	4.19e-05	0.000143	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PSMA4—liver cancer	4.19e-05	0.000143	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTA4—liver cancer	4.19e-05	0.000143	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	4.18e-05	0.000143	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—NAT2—liver cancer	4.17e-05	0.000142	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.09e-05	0.00014	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTA2—liver cancer	4.08e-05	0.000139	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GOT2—liver cancer	4.07e-05	0.000139	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALDOB—liver cancer	3.99e-05	0.000136	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTP1—liver cancer	3.98e-05	0.000136	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CB—liver cancer	3.96e-05	0.000135	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—KRAS—liver cancer	3.94e-05	0.000135	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTA1—liver cancer	3.94e-05	0.000134	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—HMOX1—liver cancer	3.92e-05	0.000134	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.92e-05	0.000134	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	3.9e-05	0.000133	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—NAT2—liver cancer	3.89e-05	0.000133	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PRKCE—liver cancer	3.87e-05	0.000132	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	3.84e-05	0.000131	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP2E1—liver cancer	3.83e-05	0.000131	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CRABP1—liver cancer	3.81e-05	0.00013	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	3.81e-05	0.00013	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—HPGDS—liver cancer	3.8e-05	0.00013	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CD—liver cancer	3.78e-05	0.000129	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.78e-05	0.000129	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.74e-05	0.000128	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—SERPINE1—liver cancer	3.74e-05	0.000128	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALDOB—liver cancer	3.73e-05	0.000127	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	3.71e-05	0.000127	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.71e-05	0.000127	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTM1—liver cancer	3.66e-05	0.000125	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PIK3CA—liver cancer	3.62e-05	0.000124	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYCS—liver cancer	3.58e-05	0.000122	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CRABP1—liver cancer	3.56e-05	0.000122	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—AKT1—liver cancer	3.54e-05	0.000121	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GOT1—liver cancer	3.52e-05	0.00012	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GGT1—liver cancer	3.52e-05	0.00012	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TP53—liver cancer	3.5e-05	0.00012	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP1A1—liver cancer	3.47e-05	0.000118	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.44e-05	0.000118	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PSMA4—liver cancer	3.39e-05	0.000116	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PSMD10—liver cancer	3.39e-05	0.000116	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—H2AFX—liver cancer	3.38e-05	0.000115	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—RAF1—liver cancer	3.38e-05	0.000115	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—HRAS—liver cancer	3.35e-05	0.000114	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—HPGDS—liver cancer	3.33e-05	0.000114	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GOT2—liver cancer	3.3e-05	0.000113	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CB—liver cancer	3.3e-05	0.000113	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—MTHFR—liver cancer	3.23e-05	0.00011	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL6—liver cancer	3.21e-05	0.00011	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.2e-05	0.000109	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	3.18e-05	0.000109	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PPARA—liver cancer	3.17e-05	0.000108	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTP1—liver cancer	3.16e-05	0.000108	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.13e-05	0.000107	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—HMOX1—liver cancer	3.11e-05	0.000106	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—HPGDS—liver cancer	3.11e-05	0.000106	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP2E1—liver cancer	3.1e-05	0.000106	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.09e-05	0.000106	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MTHFR—liver cancer	3.06e-05	0.000105	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TERT—liver cancer	3.05e-05	0.000104	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IL2—liver cancer	3.03e-05	0.000103	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3e-05	0.000102	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PSMD10—liver cancer	2.97e-05	0.000101	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PSMA4—liver cancer	2.97e-05	0.000101	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—AKT1—liver cancer	2.96e-05	0.000101	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	2.92e-05	9.98e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTM1—liver cancer	2.9e-05	9.91e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYCS—liver cancer	2.9e-05	9.9e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GOT2—liver cancer	2.89e-05	9.86e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.85e-05	9.73e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GOT1—liver cancer	2.84e-05	9.72e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GGT1—liver cancer	2.84e-05	9.72e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.83e-05	9.67e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.82e-05	9.62e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.78e-05	9.5e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PSMD10—liver cancer	2.77e-05	9.47e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PSMA4—liver cancer	2.77e-05	9.47e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP1A1—liver cancer	2.75e-05	9.4e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP2E1—liver cancer	2.71e-05	9.27e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CG—liver cancer	2.71e-05	9.27e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GOT2—liver cancer	2.7e-05	9.21e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PPARG—liver cancer	2.62e-05	8.95e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—APC—liver cancer	2.57e-05	8.79e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—VEGFA—liver cancer	2.57e-05	8.79e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—MTHFR—liver cancer	2.57e-05	8.76e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.56e-05	8.74e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTP1—liver cancer	2.56e-05	8.73e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYCS—liver cancer	2.54e-05	8.68e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP2E1—liver cancer	2.54e-05	8.66e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—HMOX1—liver cancer	2.52e-05	8.61e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PPARA—liver cancer	2.52e-05	8.6e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GGT1—liver cancer	2.49e-05	8.51e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GOT1—liver cancer	2.49e-05	8.51e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.46e-05	8.39e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—BRAF—liver cancer	2.42e-05	8.26e-05	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CA—liver cancer	2.41e-05	8.25e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CD—liver cancer	2.39e-05	8.15e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYCS—liver cancer	2.37e-05	8.11e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TGFB1—liver cancer	2.36e-05	8.06e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ALB—liver cancer	2.36e-05	8.05e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTM1—liver cancer	2.35e-05	8.02e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GGT1—liver cancer	2.33e-05	7.95e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GOT1—liver cancer	2.33e-05	7.95e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CD—liver cancer	2.26e-05	7.73e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.26e-05	7.72e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTP1—liver cancer	2.24e-05	7.65e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SERPINE1—liver cancer	2.24e-05	7.64e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP1A1—liver cancer	2.23e-05	7.6e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—HMOX1—liver cancer	2.21e-05	7.54e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—KRAS—liver cancer	2.19e-05	7.47e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CG—liver cancer	2.16e-05	7.36e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTP1—liver cancer	2.09e-05	7.14e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CB—liver cancer	2.08e-05	7.11e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PPARG—liver cancer	2.08e-05	7.11e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—MTHFR—liver cancer	2.08e-05	7.09e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—HMOX1—liver cancer	2.06e-05	7.05e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTM1—liver cancer	2.06e-05	7.03e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PPARA—liver cancer	2.04e-05	6.95e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RAF1—liver cancer	2.02e-05	6.9e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CA—liver cancer	2.01e-05	6.86e-05	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—AKT1—liver cancer	1.97e-05	6.74e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MTOR—liver cancer	1.97e-05	6.74e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CB—liver cancer	1.97e-05	6.74e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP1A1—liver cancer	1.95e-05	6.66e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TP53—liver cancer	1.94e-05	6.64e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTM1—liver cancer	1.92e-05	6.57e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CD—liver cancer	1.89e-05	6.47e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ALB—liver cancer	1.87e-05	6.39e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—HRAS—liver cancer	1.86e-05	6.35e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CDKN1B—liver cancer	1.85e-05	6.32e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.83e-05	6.25e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP1A1—liver cancer	1.82e-05	6.22e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—MTHFR—liver cancer	1.82e-05	6.21e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PPARA—liver cancer	1.78e-05	6.09e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CTNNB1—liver cancer	1.75e-05	5.97e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CG—liver cancer	1.74e-05	5.96e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CDKN1A—liver cancer	1.71e-05	5.83e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—MTHFR—liver cancer	1.7e-05	5.8e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PPARG—liver cancer	1.68e-05	5.75e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PPARA—liver cancer	1.67e-05	5.69e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CB—liver cancer	1.65e-05	5.64e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—AKT1—liver cancer	1.64e-05	5.61e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CD—liver cancer	1.53e-05	5.24e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CG—liver cancer	1.53e-05	5.22e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—STAT3—liver cancer	1.52e-05	5.21e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.5e-05	5.11e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PPARG—liver cancer	1.47e-05	5.04e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CG—liver cancer	1.43e-05	4.88e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MYC—liver cancer	1.42e-05	4.84e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TGFB1—liver cancer	1.41e-05	4.83e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PPARG—liver cancer	1.38e-05	4.71e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CD—liver cancer	1.34e-05	4.59e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CB—liver cancer	1.34e-05	4.56e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALB—liver cancer	1.33e-05	4.53e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—KRAS—liver cancer	1.31e-05	4.47e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CA—liver cancer	1.27e-05	4.33e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CD—liver cancer	1.25e-05	4.29e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALB—liver cancer	1.24e-05	4.23e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CA—liver cancer	1.2e-05	4.11e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CB—liver cancer	1.17e-05	4e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HRAS—liver cancer	1.11e-05	3.8e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CB—liver cancer	1.09e-05	3.74e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IL6—liver cancer	1.06e-05	3.64e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—AKT1—liver cancer	1.04e-05	3.54e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CA—liver cancer	1.01e-05	3.44e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—AKT1—liver cancer	9.82e-06	3.35e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—AKT1—liver cancer	8.22e-06	2.81e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CA—liver cancer	8.14e-06	2.78e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CA—liver cancer	7.14e-06	2.44e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CA—liver cancer	6.67e-06	2.28e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—AKT1—liver cancer	6.65e-06	2.27e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—AKT1—liver cancer	5.83e-06	1.99e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—AKT1—liver cancer	5.45e-06	1.86e-05	CbGpPWpGaD
